

Preterm Birth and Premature Rupture of Membranes
(PROM) Testing Market
Preterm Birth and Premature Rupture of Membranes
(PROM) Testing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031


Request Sample Report

Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market Size and Growth
The Preterm Birth and Premature Rupture of Membranes (PROM) Testing market research reports indicate a growing demand for diagnostic tests due to increasing preterm birth rates. The market size is estimated to be worth $1.5 billion, driven by technological advancements and rising awareness about the importance of early detection and management of preterm birth risks.

Request Sample Report

Companies Covered (Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Biosynex
◍ Cooper Surgical
◍ Hologic
◍ IQ Products
◍ Medix Biochemica
◍ Parsagen Diagnostics , Inc
◍ Qiagen
◍ Sera Prognostics

The competitive landscape of the Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market includes companies such as Abbott Laboratories, Biosynex, Cooper Surgical, Hologic, IQ Products, Medix Biochemica, Parsagen Diagnostics, Qiagen, and Sera Prognostics. These companies offer various diagnostic tests and tools to help identify and manage preterm birth and PROM to healthcare providers and patients, thereby contributing to the market growth.
- Abbott Laboratories reported sales revenue of $22.3 billion in 2020.
- Hologic reported sales revenue of $3.1 billion in 2020.
Request Sample Report


Market Segmentation
By Application
◍ Hospitals
◍ Diagnostic Laboratories
◍ Other
Request Sample Report
0
By Product















